Claire Novorol worked as a Pediatrician in London before specialising in Clinical Genetics. She has degrees in Pathology and Medicine as well as a PhD in Neuroscience from the University of Cambridge. Her thesis was on "Microcephaly models in the developing zebrafish retinal neuroepithelium" for her 2014 PhD.
She is founder and Chief Medical Officer of Ada Health, an AI-powered health guide that helps people to understand their health and navigate to the next appropriate steps in their care. ADA Health has ranked as the top medical app in over 130 countries and raised $67 million since 2012.
Novorol is also the founder of Doctorpreneurs, a non-profit global community for health innovation.
Novorol is member of the UK Digital Health Council. She is at Saïd Business School, University of Oxford considered as an entrepreneurship expert.
In 2018 she has been recognized as one of the Europe's Top Women in Tech 2018 by the magazine Forbes.
According to Google Scholar, she has 3 scientific publications:
Novorol CL, Chin RF, Scott RC. Outcome of convulsive status epilepticus: a review. Archives of disease in childhood. 2007 Nov 1;92(11):948-51. Cited 46 times.
Novorol, C., Burkhardt, J., Wood, K.J., Iqbal, A., Roque, C., Coutts, N., Almeida, A.D., He, J., Wilkinson, C.J. and Harris, W.A., 2013. Microcephaly models in the developing zebrafish retinal neuroepithelium point to an underlying defect in metaphase progression. Open biology, 3(10), p.130065. Cited 40 times
Lupo, G., Novorol, C., Smith, J.R., Vallier, L., Miranda, E., Alexander, M., Biagioni, S., Pedersen, R.A. and Harris, W.A., 2013. Multiple roles of Activin/Nodal, bone morphogenetic protein, fibroblast growth factor and Wnt/β-catenin signalling in the anterior neural patterning of adherent human embryonic stem cell cultures. Open biology, 3(4), p.120167. Cited 33 times
She appeared in a panel on the Web Summit 2018 to discuss if health apps are really as healthy as perceived.